FDA
approval
· 2016-10-14
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hisun Pharmaceuticals USA Inc.)
Summary
FDA approved a generic fixed-dose combination tablet of irbesartan and hydrochlorothiazide from Hisun Pharmaceuticals USA Inc. for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)